Amlodipine Besylate and Benazepril Hydrochloride (Sandoz Inc)
Welcome to the PulseAid listing for the Amlodipine Besylate and Benazepril Hydrochloride drug offered from Sandoz Inc. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | amlodipine besylate and benazepril hydrochloride |
SUBSTANCE NAME: | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 1995-03-03 |
END MARKETING DATE: | 0000-00-00 |
Amlodipine Besylate and Benazepril Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Amlodipine Besylate and Benazepril Hydrochloride from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5; 10(mg/1; mg/1) |
START MARKETING DATE: | 1995-03-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-2271_ee885922-cc1f-4cf5-89ff-43714520d1fa |
PRODUCT NDC: | 0781-2271 |
APPLICATION NUMBER: | NDA020364 |
Other AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: